BRISTOL-MYERS SQUIBB COMPANY Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31)
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) of $1.00 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-02-13.
Discontinued › Notes
us-gaap:UndistributedEarningsAllocatedToParticipatingSecurities · last filed 2015-02-13
- BRISTOL-MYERS SQUIBB COMPANY undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2012-09-30 was -$1.00M, a 150.00% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2012-06-30 was $1.00M, a 50.00% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2012-03-31 was $1.00M, a 50.00% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY undistributed earnings allocated to participating securities (deprecated 2014-01-31) for fiscal 2012 was $1.00M, a 87.50% decline from fiscal 2011.
- BRISTOL-MYERS SQUIBB COMPANY undistributed earnings allocated to participating securities (deprecated 2014-01-31) for fiscal 2011 was $8.00M, a 33.33% decline from fiscal 2010.
- BRISTOL-MYERS SQUIBB COMPANY undistributed earnings allocated to participating securities (deprecated 2014-01-31) for fiscal 2010 was $12.00M, a 33.33% decline from fiscal 2009.
- BRISTOL-MYERS SQUIBB COMPANY undistributed earnings allocated to participating securities (deprecated 2014-01-31) for fiscal 2009 was $18.00M.
| Period end | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 3 month | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 6 month | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 9 month | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$1.00M derived: sum of 2 quarters · filed 2015-02-13 | $0.00 derived: sum of 3 quarters · filed 2015-02-13 | $1.00M 10-K · filed 2015-02-13 |
| 2012-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $0.00 derived: sum of 2 quarters · filed 2013-10-23 | $1.00M 10-Q · filed 2013-10-23 | $3.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $2.00M 10-Q · filed 2013-07-25 | $4.00M derived: sum of 3 quarters · filed 2014-02-14 | $6.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | $1.00M 10-Q · filed 2013-04-25 | $3.00M derived: sum of 2 quarters · filed 2014-02-14 | $5.00M derived: sum of 3 quarters · filed 2014-02-14 | $7.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2011-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $4.00M derived: sum of 2 quarters · filed 2014-02-14 | $6.00M derived: sum of 3 quarters · filed 2014-02-14 | $8.00M 10-K · filed 2014-02-14 |
| 2011-09-30 | $2.00M 10-Q · filed 2012-10-24 | $4.00M derived: sum of 2 quarters · filed 2012-10-24 | $6.00M 10-Q · filed 2012-10-24 | $7.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $2.00M 10-Q · filed 2012-07-25 | $4.00M 10-Q · filed 2012-07-25 | $5.00M derived: sum of 3 quarters · filed 2013-02-15 | $9.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $2.00M 10-Q · filed 2012-04-26 | $3.00M derived: sum of 2 quarters · filed 2013-02-15 | $7.00M derived: sum of 3 quarters · filed 2013-02-15 | $10.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $5.00M derived: sum of 2 quarters · filed 2013-02-15 | $8.00M derived: sum of 3 quarters · filed 2013-02-15 | $12.00M 10-K · filed 2013-02-15 |
| 2010-09-30 | $4.00M 10-Q · filed 2011-10-27 | $7.00M derived: sum of 2 quarters · filed 2011-10-27 | $11.00M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $3.00M 10-Q · filed 2011-07-28 | $7.00M 10-Q · filed 2011-07-28 | ||
| 2009-12-31 | $18.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |